147366-41-4,MFCD00953420
Catalog No.:AA001ES8

147366-41-4 | Pyridinium, 1-ethyl-2-[[3-ethyl-5-(3-methyl-2(3H)-benzothiazolylidene)-4-oxo-2-thiazolidinylidene]methyl]-, chloride (1:1)

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
95%
in stock  
$16.00   $12.00
- +
5mg
95%
in stock  
$39.00   $27.00
- +
10mg
95%
in stock  
$58.00   $41.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA001ES8
Chemical Name:
Pyridinium, 1-ethyl-2-[[3-ethyl-5-(3-methyl-2(3H)-benzothiazolylidene)-4-oxo-2-thiazolidinylidene]methyl]-, chloride (1:1)
CAS Number:
147366-41-4
Molecular Formula:
C21H22ClN3OS2
Molecular Weight:
432.0019
MDL Number:
MFCD00953420
SMILES:
CCn1c(=Cc2cccc[n+]2CC)sc(=c2sc3c(n2C)cccc3)c1=O.[Cl-]
Properties
Computed Properties
 
Complexity:
647  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
2  
Formal Charge:
0  
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Literature

Title: Withanone binds to mortalin and abrogates mortalin-p53 complex: computational and experimental evidence.

Journal: The international journal of biochemistry & cell biology 20120301

Title: Uptake rate of cationic mitochondrial inhibitor MKT-077 determines cellular oxygen consumption change in carcinoma cells.

Journal: PloS one 20120101

Title: Mortalin inhibition in experimental Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society 20110801

Title: Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.

Journal: International journal of cancer 20100315

Title: Fluorinated rhodacyanine (SJL-01) possessing high efficacy for visceral leishmaniasis (VL).

Journal: Journal of medicinal chemistry 20100114

Title: The selective in vitro cytotoxicity of carcinoma cells by AZT is enhanced by concurrent treatment with delocalized lipophilic cations.

Journal: Cancer letters 20030730

Title: Potentiation of the antiproliferative activity of MKT-077 by loperamide, diltiazem and tamoxifen.

Journal: Oncology reports 20030101

Title: Mortalin: a potential candidate for biotechnology and biomedicine.

Journal: Histology and histopathology 20021001

Title: Starenki D, et al. Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo. Endocrinol Metab (Seoul). 2015 Dec;30(4):593-603.

Title: Li X, et al. Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents. ACS Med Chem Lett. 2013 Nov 14;4(11).

Title: Weisberg EL, et al. In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function. Cancer Res. 1996 Feb 1;56(3):551-5.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 147366-41-4
Tags:147366-41-4 Molecular Formula|147366-41-4 MDL|147366-41-4 SMILES|147366-41-4 Pyridinium, 1-ethyl-2-[[3-ethyl-5-(3-methyl-2(3H)-benzothiazolylidene)-4-oxo-2-thiazolidinylidene]methyl]-, chloride (1:1)
Catalog No.: AA001ES8
147366-41-4,MFCD00953420
147366-41-4 | Pyridinium, 1-ethyl-2-[[3-ethyl-5-(3-methyl-2(3H)-benzothiazolylidene)-4-oxo-2-thiazolidinylidene]methyl]-, chloride (1:1)
Pack Size: 1mg
Purity: 95%
in stock
$16.00 $12.00
Pack Size: 5mg
Purity: 95%
in stock
$39.00 $27.00
Pack Size: 10mg
Purity: 95%
in stock
$58.00 $41.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA001ES8
Chemical Name: Pyridinium, 1-ethyl-2-[[3-ethyl-5-(3-methyl-2(3H)-benzothiazolylidene)-4-oxo-2-thiazolidinylidene]methyl]-, chloride (1:1)
CAS Number: 147366-41-4
Molecular Formula: C21H22ClN3OS2
Molecular Weight: 432.0019
MDL Number: MFCD00953420
SMILES: CCn1c(=Cc2cccc[n+]2CC)sc(=c2sc3c(n2C)cccc3)c1=O.[Cl-]
Properties
Complexity: 647  
Covalently-Bonded Unit Count: 2  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 2  
Formal Charge: 0  
Heavy Atom Count: 28  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Literature fold

Title: Withanone binds to mortalin and abrogates mortalin-p53 complex: computational and experimental evidence.

Journal: The international journal of biochemistry & cell biology20120301

Title: Uptake rate of cationic mitochondrial inhibitor MKT-077 determines cellular oxygen consumption change in carcinoma cells.

Journal: PloS one20120101

Title: Mortalin inhibition in experimental Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society20110801

Title: Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.

Journal: International journal of cancer20100315

Title: Fluorinated rhodacyanine (SJL-01) possessing high efficacy for visceral leishmaniasis (VL).

Journal: Journal of medicinal chemistry20100114

Title: The selective in vitro cytotoxicity of carcinoma cells by AZT is enhanced by concurrent treatment with delocalized lipophilic cations.

Journal: Cancer letters20030730

Title: Potentiation of the antiproliferative activity of MKT-077 by loperamide, diltiazem and tamoxifen.

Journal: Oncology reports20030101

Title: Mortalin: a potential candidate for biotechnology and biomedicine.

Journal: Histology and histopathology20021001

Title: Starenki D, et al. Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo. Endocrinol Metab (Seoul). 2015 Dec;30(4):593-603.

Title: Li X, et al. Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents. ACS Med Chem Lett. 2013 Nov 14;4(11).

Title: Weisberg EL, et al. In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function. Cancer Res. 1996 Feb 1;56(3):551-5.

Building Blocks More >
147700-11-6
147700-11-6
1H-Purine-2,6-dione, 8-[(1E)-2-(3-chlorophenyl)ethenyl]-3,7-dihydro-1,3,7-trimethyl-
AA001F20 | MFCD00934671
14807-39-7
14807-39-7
5,6,7,8-Tetrahydroquinolin-4-amine
AA001FC4 | MFCD18909186
141-36-6
141-36-6
(+/-)-Trans-epoxysuccinic acid
AA001FMP | MFCD01074888
141342-92-9
141342-92-9
α-D-Galactopyranoside, methyl 2-(acetylamino)-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-
AA001G71 | MFCD02094277
1416366-34-1
1416366-34-1
2-Chloro-5-(methoxymethyl)pyrimidine
AA001GOE | MFCD28385449
1417861-92-7
1417861-92-7
Siloxanes and Silicones, di-Me, Bu group-terminated
AA001H3P
1420477-60-6
1420477-60-6
Acalabrutinib
AA001HJK | MFCD29472294
14222-60-7
14222-60-7
Protionamide
AA001HX3 | MFCD00464119
1438241-20-3
1438241-20-3
(3-Methoxycyclobutyl)methanamine
AA001ICG | MFCD21337860
14405-03-9
14405-03-9
Acetamide, 2-chloro-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-
AA001IS1 | MFCD00000927
Submit
© 2017 AA BLOCKS, INC. All rights reserved.